- Report
- June 2023
- 159 Pages
Global
From €6622EUR$7,500USD£5,747GBP
- Report
- May 2024
- 132 Pages
Global
From €5738EUR$6,499USD£4,980GBP
- Report
- May 2024
- 134 Pages
Global
From €5738EUR$6,499USD£4,980GBP
- Report
- May 2024
- 128 Pages
Global
From €5738EUR$6,499USD£4,980GBP
- Report
- May 2024
- 137 Pages
Global
From €5738EUR$6,499USD£4,980GBP
- Report
- June 2024
- 200 Pages
Global
From €7020EUR$7,950USD£6,091GBP
- Report
- August 2022
- 111 Pages
Global
From €4194EUR$4,750USD£3,640GBP
- Report
- April 2023
- 147 Pages
Global
From €4370EUR$4,949USD£3,792GBP
- Report
- April 2023
- 147 Pages
Global
From €4370EUR$4,949USD£3,792GBP
- Report
- March 2023
- 147 Pages
Global
From €4370EUR$4,949USD£3,792GBP
- Drug Pipelines
- August 2024
- 150 Pages
Global
From €2463EUR$2,789USD£2,137GBP
- Report
- May 2023
- 160 Pages
Global
From €4370EUR$4,949USD£3,792GBP
The Seizure Drug market is a subset of the Central Nervous System Drugs market, which includes drugs used to treat neurological disorders. Seizure Drugs are used to treat epilepsy, a neurological disorder characterized by recurrent seizures. These drugs work by reducing the frequency and severity of seizures, and can be administered orally, intravenously, or rectally. Commonly used Seizure Drugs include anticonvulsants, benzodiazepines, and barbiturates.
Seizure Drugs are typically prescribed by neurologists and other healthcare professionals. The market is highly competitive, with many companies offering a variety of drugs. Some of the major players in the Seizure Drug market include Pfizer, GlaxoSmithKline, Novartis, Sanofi, and Johnson & Johnson. Show Less Read more
